A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

NCT01077531 ·Status: TERMINATED ·Phase: PHASE1

A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis

NCT01462162 ·Status: COMPLETED

Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis

NCT01063803 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

NCT00411424 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects

NCT03606876 ·Status: COMPLETED ·Phase: PHASE1

A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis

NCT01223911 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

NCT02534896 ·Status: TERMINATED ·Phase: PHASE3

A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

NCT01672970 ·Status: COMPLETED

A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis

NCT01251120 ·Status: TERMINATED ·Phase: PHASE4

Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis

NCT05428488 ·Status: RECRUITING ·Phase: PHASE3

Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870

NCT02586246 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis

NCT02919761 ·Status: COMPLETED ·Phase: PHASE4

An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

NCT01543503 ·Status: COMPLETED

A Long-Term Extension Study of WA22763 and NA25220 of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

NCT01772316 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients

NCT01061736 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT01565122 ·Status: COMPLETED

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate

NCT01636843 ·Status: TERMINATED ·Phase: PHASE2

Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

NCT03830203 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)

NCT01667458 ·Status: COMPLETED

Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)

NCT02858492 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis

NCT01282255 ·Status: COMPLETED ·Phase: PHASE2

Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis

NCT06016517 ·Status: NOT_YET_RECRUITING

Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients

NCT01559103 ·Status: TERMINATED ·Phase: PHASE1

Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients

NCT00124449 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA)

NCT02121210 ·Status: COMPLETED ·Phase: PHASE3